OXB OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for...
lentiviral
OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic...
Lentiviral vectors are one of the foundational technologies of cell and gene therapy. Along with adenoviral vectors, they are one...
Cytegrity technology will aid in cost-effective lentiviral vector production for gene and cell therapies. Credit: Akimov Igor / Shutterstock.com. Contract...
